Peptide Analogue for Treatment of Diabetes or Obesity

Sun, 12 Apr 2026 03:20:13 +0000
Intellectual Property

USPTO published patent application US20260097101A1 for a peptide analogue of pancreatic polypeptide (PP) intended for treating diabetes or obesity. Filed September 6, 2023 under application number 19110570, the invention also covers methods of treatment and use in manufacturing a medicament for these conditions.